|
1.
|
Kischkel FC, Lawrence DA, Chuntharapai A,
Schow P, Kim KJ and Ashkenazi A: Apo2L/TRAIL-dependent recruitment
of endogenous FADD and caspase-8 to death receptors 4 and 5.
Immunity. 12:611–620. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Deveraux QL, Roy N, Stennicke HR, et al:
IAPs block apoptotic events induced by caspase-8 and cytochrome c
by direct inhibition of distinct caspases. EMBO J. 17:2215–2223.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Hu W, Johnson H and Shu H: Tumor necrosis
factor-related apoptosis-inducing ligand receptors signal NF-κB and
JNK activation and apoptosis through distinct pathways. J Biol
Chem. 274:306031999.
|
|
4.
|
Lin B, Williams-Skipp C, Tao Y, et al:
NF-κB functions as both a proapoptotic and antiapoptotic regulatory
factor within a single cell type. Cell Death Differ. 6:570–582.
1999.
|
|
5.
|
Son YG, Kim EH, Kim JY, et al: Silibinin
sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5
up-regulation and down-regulation of c-FLIP and survivin. Cancer
Res. 67:8274–8284. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Ding L, Yuan C, Wei F, et al: Cisplatin
restores TRAIL apoptotic pathway in glioblastoma-derived stem cells
through up-regulation of DR5 and down-regulation of c-FLIP. Cancer
Invest. 29:511–520. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Park SJ, Bijangi-Vishehsaraei K and Safa
AR: Selective TRAIL-triggered apoptosis due to overexpression of
TRAIL death receptor 5 (DR5) in P-glycoprotein-bearing multidrug
resistant CEM/VBL1000 human leukemia cells. Int J Biochem Mol Biol.
1:90–100. 2010.
|
|
8.
|
Fossati S, Ghiso J and Rostagno A: TRAIL
death receptors DR4 and DR5 mediate cerebral microvascular
endothelial cell apoptosis induced by oligomeric Alzheimer’s Aβ.
Cell Death Dis. 3:e3212012.PubMed/NCBI
|
|
9.
|
Griffith TS, Fialkov JM, Scott DL, et al:
Induction and regulation of tumor necrosis factor-related
apoptosis–inducing ligand/Apo-2 ligand-mediated apoptosis in renal
cell carcinoma. Cancer Res. 62:3093–3099. 2002.
|
|
10.
|
Kim JY, Lee JY, Kim DG, Koo GB, Yu JW and
Kim YS: TRADD is critical for resistance to TRAIL-induced cell
death through NF-κB activation. FEBS Lett. 585:2144–2150. 2011.
|
|
11.
|
Tian X, Ye J, Alonso-Basanta M, Hahn SM,
Koumenis C and Dorsey JF: Modulation of CCAAT/enhancer binding
protein homologous protein (CHOP)-dependent DR5 expression by
nelfinavir sensitizes glioblastoma multiforme cells to tumor
necrosis factor-related apoptosis-inducing ligand (TRAIL). J Biol
Chem. 286:29408–29416. 2011. View Article : Google Scholar
|
|
12.
|
Carr BI: Hepatocellular carcinoma: current
management and future trends. Gastroenterology. 127:S218–S224.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Yang JF, Cao JG, Tian L and Liu F:
5,7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5
upregulation in hepatocellular carcinoma cells. Cancer Chemother
Pharmacol. 69:195–206. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Zhang B, Shan H, Li D, et al: Cisplatin
sensitizes human hepatocellular carcinoma cells, but not
hepatocytes and mesenchymal stem cells, to TRAIL within a
therapeutic window partially depending on the upregulation of DR5.
Oncol Rep. 25:461–468. 2011.
|
|
15.
|
Lee SA, Jo HK, Im BO, Kim SU, Whang WK and
Ko SK: Changes in the Contents of Prosapogenin in the Red Ginseng
(Panax ginseng) Depending on Steaming Batches. J Ginseng Res.
36:102–106. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
In G, Ahn NG, Bae BS, Han ST, Noh KB and
Kim CS: New method for simultaneous quantification of 12
ginsenosides in red ginseng powder and extract: in-house method
validation. J Ginseng Res. 36:205–210. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Sun S, Qi LW, Du GJ, Mehendale SR, Wang CZ
and Yuan CS: Red notoginseng: higher ginsenoside content and
stronger anti-cancer potential than Asian and American ginseng.
Food Chem. 125:1299–1305. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Keum YS, Park KK, Lee JM, et al:
Antioxidant and anti-tumor promoting activities of the methanol
extract of heat-processed ginseng. Cancer Lett. 150:41–48. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Li J, Huang M, Teoh H and Man RY: Panax
quinquefolium saponins protects low density lipoproteins from
oxidation. Life Sci. 64:53–62. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Chang MS, Lee SG and Rho HM:
Transcriptional activation of Cu/Zn superoxide dismutase and
catalase genes by panaxadiol ginsenosides extracted from Panax
ginseng. Phytother Res. 13:641–644. 1999. View Article : Google Scholar
|
|
21.
|
Ji HY, Lee HW, Kim HK, et al: Simultaneous
determination of ginsenoside Rb(1) and Rg(1) in human plasma by
liquid chromatography-mass spectrometry. J Pharm Biomed Anal.
35:207–212. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Cai F, Sun L, Gao S, Yang Y, Yang Q and
Chen W: A rapid and sensitive liquid chromatography-tandem mass
spectrometric method for the determination of timosaponin B-II in
blood plasma and a study of the pharmacokinetics of saponin in the
rat. J Pharm Biomed Anal. 48:1411–1416. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Woo SS, Song JS, Lee JY, et al: Selection
of high ginsenoside producing ginseng hairy root lines using
targeted metabolic analysis. Phytochemistry. 65:2751–2761. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Park JD, Rhee DK and Lee YH: Biological
activities and chemistry of saponins from Panax ginseng CA Meyer.
Phytochem Rev. 4:159–175. 2005. View Article : Google Scholar
|
|
25.
|
Lee DCW and Lau ASY: Effects of Panax
ginseng on tumor necrosis factor-α-mediated inflammation: a
mini-review. Molecules. 16:2802–2816. 2011.
|
|
26.
|
Sayers TJ: Targeting the extrinsic
apoptosis signaling pathway for cancer therapy. Cancer Immunology,
Immunotherapy. 1–8. 2011.
|
|
27.
|
Ravi R, Bedi GC, Engstrom LW, et al:
Regulation of death receptor expression and TRAIL/Apo2L-induced
apoptosis by NF-κB. Nat Cell Biol. 3:409–416. 2001.
|
|
28.
|
Ganten TM, Koschny R, Sykora J, et al:
Preclinical differentiation between apparently safe and potentially
hepatotoxic applications of TRAIL either alone or in combination
with chemotherapeutic drugs. Clin Cancer Res. 12:2640–2646. 2006.
View Article : Google Scholar
|
|
29.
|
Baritaki S, Huerta-Yepez S, Sakai T,
Spandidos DA and Bonavida B: Chemotherapeutic drugs sensitize
cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and
inhibition of Yin Yang 1. Mol Cancer Ther. 6:1387–1399. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Mellier G, Huang S, Shenoy K and Pervaiz
S: TRAILing death in cancer. Mol Aspects Med. 31:93–112. 2010.
View Article : Google Scholar
|
|
31.
|
Kouhara J, Yoshida T, Nakata S, et al:
Fenretinide upregulates DR5/TRAIL-R2 expression via the induction
of the transcription factor CHOP and combined treatment with
fenretinide and TRAIL induces synergistic apoptosis in colon cancer
cell lines. Int J Oncol. 30:679–687. 2007.
|
|
32.
|
Bertram H, Nerlich A, Omlor G, Geiger F,
Zimmermann G and Fellenberg J: Expression of TRAIL and the death
receptors DR4 and DR5 correlates with progression of degeneration
in human intervertebral disks. Mod Pathol. 22:895–905. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Xiaowen H and Yi S: Triptolide sensitizes
TRAIL-induced apoptosis in prostate cancer cells via p53-mediated
DR5 up-regulation. Mol Biol Rep. 39:8763–8770. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Lin FL, Hsu JL, Chou CH, Wu WJ, Chang CI
and Liu HJ: Activation of p38 MAPK by damnacanthal mediates
apoptosis in SKHep 1 cells through the DR5/TRAIL and TNFR1/TNF-α
and p53 pathways. Eur J Pharmacol. 650:120–129. 2011.PubMed/NCBI
|
|
35.
|
Deng Z, Yan H, Hu J, et al: Hepatitis C
virus sensitizes host cells to TRAIL-induced apoptosis by
up-regulating DR4 and DR5 via a MEK1-dependent pathway. PloS One.
7:e377002012. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Shiraishi T, Yoshida T, Nakata S, et al:
Tunicamycin enhances tumor necrosis factor-related
apoptosis-inducing ligand-induced apoptosis in human prostate
cancer cells. Cancer Res. 65:6364–6370. 2005. View Article : Google Scholar
|
|
37.
|
Chen CY, Yiin SJ, Hsu JL, Wang WC, Lin SC
and Chern CL: Isoobtusilactone A sensitizes human hepatoma Hep G2
cells to TRAIL-induced apoptosis via ROS and CHOP-mediated
up-regulation of DR5. J Agric Food Chem. 60:3533–3539. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Oyadomari S and Mori M: Roles of
CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ.
11:381–389. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Bin L, Thorburn J, Thomas LR, Clark PE,
Humphreys R and Thorburn A: Tumor-derived mutations in the TRAIL
receptor DR5 inhibit TRAIL signaling through the DR4 receptor by
competing for ligand binding. J Biol Chem. 282:28189–28194. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Sheridan JP, Marsters SA, Pitti RM, et al:
Control of TRAIL-induced apoptosis by a family of signaling and
decoy receptors. Science. 277:818–821. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Seol DW: p53-Independent up-regulation of
a TRAIL receptor DR5 by proteasome inhibitors: a mechanism for
proteasome inhibitor-enhanced TRAIL-induced apoptosis. Biochem
Biophys Res Commun. 416:222–225. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Sung B, Ravindran J, Prasad S, Pandey MK
and Aggarwal BB: Gossypol induces death receptor-5 through
activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer
cells to TRAIL. J Biol Chem. 285:35418–35427. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Zinszner H, Kuroda M, Wang X, et al: CHOP
is implicated in programmed cell death in response to impaired
function of the endoplasmic reticulum. Genes Dev. 12:982–995. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Zou W, Yue P, Khuri F and Sun S: Coupling
of endoplasmic reticulum stress to CDDO-Me-induced up-regulation of
death receptor 5 via a CHOP-dependent mechanism involving JNK
activation. Cancer Res. 68:7484–7492. 2008. View Article : Google Scholar : PubMed/NCBI
|
